A 58-year-old with non-purulent cellulitis and systemic signs is started on IV cefazolin. He also has gout. For discharge, which step reduces CDI risk...

Question

A 58-year-old with non-purulent cellulitis and systemic signs is started on IV cefazolin. He also has gout. For discharge, which step reduces CDI risk while maintaining efficacy if he develops CDI history later?

Accepted Answer

Use bezlotoxumab adjunct in high-risk CDI recurrence

Answer

Prefer fidaxomicin over vancomycin to treat future CDI recurrences

Answer

Add metronidazole to future CDI therapy routinely

Answer

Use prolonged oral vancomycin taper for first CDI

Answer

Avoid future CDI treatment if symptoms mild

us-abim MCQ (SBA): C. difficile Prevention of Recurrence

A 58-year-old with non-purulent cellulitis and systemic signs is started on IV cefazolin. He also has gout. For discharge, which step reduces CDI risk while maintaining efficacy if he develops CDI history later?